Krzystanek E, Krzystanek M, Opala G, Trzeciak H I, Siuda J, Małecki A
Department of Late Age Neurology, Silesian Medical University, Katowice, Poland.
J Neural Transm (Vienna). 2007;114(8):1033-9. doi: 10.1007/s00702-007-0669-9. Epub 2007 Apr 20.
Phospholipase A(2) (E.C. 3.1.1.4, PLA(2)) plays an essential role in metabolism of membrane phospholipids, it is related to inflammatory reactions, secretion of amyloid precursor protein and activation of NMDA receptor after ischemia. In the present study we investigated PLA(2) activity in platelets from 37 Alzheimer's disease (AD) patients, 32 vascular dementia (VaD) patients and 32 individuals with ischemic stroke as compared to 27 healthy elderly controls. PLA(2) activity was determined using radiometric assay. Mean platelet PLA(2) activity was increased in individuals with Alzheimer's disease (p < 0.001). In VaD group the enzyme activity was between the values in AD and controls, these differences being significant from both groups. In the group of patients with ischemic stroke mean PLA(2) activity was higher either 48 h after the stroke or 7 days later (in both cases p < 0.001). The results may be particularly interesting in light of the fact, that inhibitors of PLA(2) activity are known.
磷脂酶A2(E.C. 3.1.1.4,PLA2)在膜磷脂代谢中起重要作用,它与炎症反应、淀粉样前体蛋白的分泌以及缺血后NMDA受体的激活有关。在本研究中,我们调查了37例阿尔茨海默病(AD)患者、32例血管性痴呆(VaD)患者和32例缺血性中风患者血小板中的PLA2活性,并与27名健康老年对照者进行比较。使用放射性测定法测定PLA2活性。阿尔茨海默病患者的平均血小板PLA2活性升高(p < 0.001)。在VaD组中,酶活性介于AD组和对照组之间,与这两组的差异均具有显著性。在缺血性中风患者组中,中风后48小时或7天后的平均PLA2活性均较高(两种情况下p < 0.001)。鉴于已知PLA2活性抑制剂,这些结果可能特别有趣。